Skip to main content

Advertisement

Log in

DAI-1 Receptor Expression in Placenta in Earlyand Late-Onset Preeclampsia

  • MORPHOLOGY AND PATHOMORPHOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

DAI-1 receptor (DNA-dependent activator of IFN-regulatory factors; DLM-1/ZBP-1) is an innate immunity cytoplasmic receptor of the DNA-recognition receptor class of antiviral immunity. DAI-1 expression reflects the severity of the inflammatory response that plays the key role in the pathogenesis of pregnancy complications. We studied DAI-1 receptor expression in the placental villi in early- and late-onset preeclampsia. In case of early-onset preeclampsia DAI-1 staining intensity was lower (p=0.01), and in case of late preeclampsia — significantly higher (p<0.005) than in the reference groups at the corresponding gestational age. There was revealed a correlation between the decrease in DAI-1 receptor expression and the severity of disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Andronova NV, Zaretskaya NV, Khodzhaeva ZS, Shchegolev AI, Khramchenko NV, Voevodin SM. Placental pathology in fetal chromosome abnormalities. Akush. Gin. 2014;(3):4-8. Russian.

  2. Zaretskaya NV, Muravenko OV, Nizyaeva NV, Stupko OK, Andronova NV, Khodzhaeva ZS, Meshalkina IV, Kan NE, Nagovitsyna MN, Shchyogolev AI, Voevodin SM, Tyutyunik VL, Bakharev VA. Somatic tissue chromosomal mosaicism in monozygotic triplets concurrent with early preeclampsia. Akush. Gin. 2016;(7):111-118. Russian.

    Google Scholar 

  3. Nizyaeva NV, Kulikova GV, Nagovitsyna MN, Kan NE, Prozorovskaya KN, Shchegolev AI, Sukhikh GT. Expression of MicroRNA-146a and MicroRNA-155 in Placental Villi in Early- and Late-Onset Preeclampsia. Bull. Exp. Biol. Med. 2017;163(3):394-399.

    Article  CAS  PubMed  Google Scholar 

  4. Nizyaeva NV, Nagovitsyna MN, Kulikova GV, Tumanova UN, Poltavtseva RA, Fedorova IA, Yushina MN, Pavlovich SV, Shchyogolev AI. Conditions for Collection of Placental Tissue Samples for Culturing of Multipotent Mesenchymal Stromal Cells. Bull. Exp. Biol. Med. 2017;162(4):501-506.

    Article  CAS  PubMed  Google Scholar 

  5. Sukhikh GT, Vanko LV. Immune factors in the etiology and pathogenesis of pregnancy complications. Akush. Gin. 2012;(1):128-136. Russain.

  6. Fedorova IA, Rudimova YV, Yushina MN, Chuprynin VD, Savilova AM. Comparative Analysis of the Proliferative Potential of Human Mesenchymal Stromal Cells from Extraembryonic Organs, Endometrium, and Adipose Tissue. Bull. Exp. Biol. Med. 2015;(4):548-554.

    Google Scholar 

  7. Shchegolev AI, Lyapin VM, Tumanova UN, Vodneva DN, Shmakov RG. Histological hanges in the placenta and vascularization of its villi in early- and late-onset preeclampsia. Arkh. Patol. 2016;78(1):13-18. Russian.

    Article  CAS  PubMed  Google Scholar 

  8. Biological DNA Sensor. The Impact of Nucleic Acids on Diseases and Vaccinology. Ishii KJ, Tang CK, eds. Elsevier, 2013.

  9. Chan G, Hemmings DG, Yurochko AD, Guilbert LJ. Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factoralpha. Am. J. Pathol. 2002;161(4):1371-1381.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Goulopoulou S, Matsumoto T, Bomfim GF, Webb RC. Toll-like receptor 9 activation: a novel mechanism linking placentaderived mitochondrial DNA and vascular dysfunction in preeclampsia. Clin. Sci. (Lond). 2012;123(7):429-435.

    Article  CAS  Google Scholar 

  11. Kulikova GV, Nizyaeva NV, Nagovitsina MN, Lyapin VM, Loginova NS, Kan NE, Tyutyunnik VL, Tyutyunnik NV, Schegolev AI. Specific features of TLR4 expression in structural elements of placenta in patients with preeclampsia. Bull. Exp. Biol. Med. 2016;160(5):718-721.

    Article  CAS  PubMed  Google Scholar 

  12. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol. 2007;58(1):21-30.

    Article  CAS  PubMed  Google Scholar 

  13. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007;448):501-505.

  14. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. WHO, 2015.

  15. Yu H, Shen Y, Ge Q, He Y, Qiao D, Ren M, Zhang J. Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia. Int. J. Mol. Sci. 2013;14(4):7571-7582.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. V. Nizyaeva.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 7, pp. 127-132, July, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nizyaeva, N.V., Kulikova, G.V., Nagovitsyna, M.N. et al. DAI-1 Receptor Expression in Placenta in Earlyand Late-Onset Preeclampsia. Bull Exp Biol Med 164, 109–114 (2017). https://doi.org/10.1007/s10517-017-3936-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3936-2

Key Words

Navigation